Gallic acid induced apoptotic events in HCT-15 colon cancer cells

Aruna Priyadharshni Subramanian1, Saravana Kumar Jaganathan1, Mahitosh Mandal1

  • 1Aruna Priyadharshni Subramanian, Saravana Kumar Jaganathan, Eko Supriyanto, Ida Idayu Muhamad, IJN-UTM Cardiovascular Engineering Centre, Faculty of Biosciences and Medical Engineering, Universiti Teknologi Malaysia, Johor Bahru 81310, Malaysia.

Abstract

Insights

Gallic acid (GA) effectively inhibits HCT-15 colon cancer cell growth by inducing apoptosis. This study demonstrates GA's potential as an anti-cancer agent by triggering reactive oxygen species (ROS) production and cell cycle arrest.

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Product Chemistry

Background:

  • Diet-derived phenolic compounds are increasingly recognized for their therapeutic potential.
  • Gallic acid (GA), a common plant phenolic, has shown various biological activities.
  • The specific anti-cancer mechanisms of GA against colon cancer cells require further elucidation.

Purpose of the Study:

  • To investigate the inhibitory action of gallic acid (GA) against HCT-15 colon cancer cells.
  • To determine the underlying mechanisms of GA-induced anti-cancer effects.
  • To evaluate GA's impact on cell proliferation, cell cycle, and apoptosis.

Main Methods:

  • Antiproliferative effects were assessed using MTT and colony formation assays.
  • Cell cycle distribution was analyzed via propidium iodide staining and flow cytometry.
  • Reactive oxygen species (ROS) levels and mitochondrial membrane potential were measured using flow cytometry.
  • Morphological changes and apoptosis were confirmed by scanning electron microscopy and Yo-Pro-1 staining.

Main Results:

  • Gallic acid exhibited an inhibitory effect on HCT-15 cells with an IC50 of 740 μmol/L.
  • GA treatment led to a time-dependent inhibition of colony formation and cell cycle arrest at the sub-G1 phase.
  • Increased ROS generation, decreased mitochondrial membrane potential, and characteristic apoptotic morphological changes were observed.
  • Apoptosis induction was confirmed by Yo-Pro-1 staining, showing a time-dependent increase in apoptotic cells.

Conclusions:

  • Gallic acid effectively inhibits HCT-15 colon cancer cell growth.
  • GA induces apoptosis in colon cancer cells in a ROS-dependent manner.
  • These findings highlight GA's potential as a therapeutic agent for colon cancer.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.5K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K